![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-7e9d2cbf1a9cdb965555ab4b325fdd369bf66df221c5eebb5527eaaa610ec139.jpg)
Biosimilar Enoxaparin for the Prevention or Treatment of Thrombosis and Cardiovascular Conditions
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.